Skip to content

Flurbiprofen Axetil for Uterine Contraction Pain

Phase IV Study of Flurbiprofen Axetil for Uterine Contraction Pain After Abortion

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00725218
Acronym
FAUCOP
Enrollment
97
Registered
2008-07-30
Start date
2008-05-31
Completion date
2008-08-31
Last updated
2008-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

NSAIDs, Postoperative pain, Analgesia, Abortion

Brief summary

Uterine contraction pain is a common problem after abortion. Optimal analgesic for such suffering is still needed to be guaranteed. Flurbiprofen Axetil is a target-distributable non-steroidal anti-inflammatory drug (NSAID) functioning via block the synthesis of prostaglandin E (PGE). The investigators hypothesized that Flurbiprofen Axetil could suppress the uterine contraction pain after abortion effectively.

Interventions

DRUGSaline

Saline 5 ml injection 10 min prior to propofol administration.

Flurbiprofen Axetil 50 mg in 5 ml injection 10min prior to propofol administration.

Sponsors

Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* ASA status I-II * Performing abortion operation (medical- or drug-induced * Requiring painless abortion

Exclusion criteria

* \< 19yrs, and \>= 45yrs * History of central active drugs administration * Drug abuse * Hypertension * Diabetes * Any other chronic diseases * Allergy to the study drugs * Habit of over-volume alcohol drinking * Records of history of centrally active drug use and psychiatry * Any organic disorders

Design outcomes

Primary

MeasureTime frame
VAS pain scoringsAt the end of the operation, 0,5,15,30,60min after operation

Secondary

MeasureTime frame
Anesthetic consumptionsAt the end of the operation
Overall VAS satisfaction scorings with analgesiaAt the end of the study
Side effectsDuring the whole period of the study
Volume of bleedingAt the end of the study

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026